Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
出版年份 2021 全文链接
标题
Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
作者
关键词
Iron overload, Oxidative stress, Reactive oxygen species, Myelodysplastic syndromes, MDS, RBC transfusion
出版物
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 163, Issue -, Pages 103367
出版商
Elsevier BV
发表日期
2021-05-29
DOI
10.1016/j.critrevonc.2021.103367
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
- (2020) Pierre Fenaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1–Risk Myelodysplastic Syndromes
- (2020) Emanuele Angelucci et al. ANNALS OF INTERNAL MEDICINE
- Iron and liver fibrosis: Mechanistic and clinical aspects
- (2019) Kosha J Mehta et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field
- (2019) Meghri Katerji et al. Oxidative Medicine and Cellular Longevity
- Genetic loss of Tmprss6 alters terminal erythroid differentiation in a mouse model of β-thalassemia intermedia
- (2019) David B. Stagg et al. HAEMATOLOGICA
- Treatment of MDS
- (2019) Uwe Platzbecker BLOOD
- The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
- (2019) David A. Sallman et al. BLOOD
- Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients
- (2019) Louise de Swart et al. HAEMATOLOGICA
- Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
- (2019) Marlijn Hoeks et al. HAEMATOLOGICA
- Force generated by myosin cross-bridges is reduced in myofibrils exposed to ROS/RNS
- (2019) Malin Persson et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- How we manage adults with myelodysplastic syndrome
- (2019) Pierre Fenaux et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions
- (2019) Heather A. Leitch et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis
- (2019) Hailing Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia
- (2018) Paul J. Schmidt et al. AMERICAN JOURNAL OF HEMATOLOGY
- A storm in the niche: Iron, oxidative stress and haemopoiesis
- (2018) Federica Pilo et al. BLOOD REVIEWS
- Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy
- (2018) Colleen A.C. Wong et al. LEUKEMIA RESEARCH
- Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial
- (2018) Martin Wermke et al. Lancet Haematology
- Iron overload in Myelodysplastic Syndromes: Evidence Based Guidelines from the Canadian Consortium on MDS
- (2018) Heather A. Leitch et al. LEUKEMIA RESEARCH
- Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes
- (2018) Amer M. Zeidan et al. ANNALS OF HEMATOLOGY
- Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
- (2017) Louise de Swart et al. HAEMATOLOGICA
- Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes
- (2017) Yanni Hua et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study
- (2017) Emanuela Messa et al. LEUKEMIA & LYMPHOMA
- New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types
- (2017) Corinna Strupp et al. LEUKEMIA RESEARCH
- Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome
- (2017) Qing-qing Zheng et al. LEUKEMIA RESEARCH
- Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years
- (2017) Roger M. Lyons et al. LEUKEMIA RESEARCH
- Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes
- (2017) Mathieu Meunier et al. Oncotarget
- Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
- (2017) Louise de Swart et al. HAEMATOLOGICA
- Iron Withholding: A Defense Against Disease
- (2017) Eugene D. Weinberg et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment
- (2017) Mark A. Smith et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia
- (2017) Laurence H. Jackson et al. Scientific Reports
- Erythroid cell mitochondria receive endosomal iron by a “kiss-and-run” mechanism
- (2016) Amel Hamdi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer
- (2016) Yachana Kataria et al. BMC GASTROENTEROLOGY
- Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes
- (2016) Shucheng Gu et al. Hematology
- Iron-induced epigenetic abnormalities of mouse bone marrow through aberrant activation of aconitase and isocitrate dehydrogenase
- (2016) Masayo Yamamoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2016) Peter L. Greenberg et al. Journal of the National Comprehensive Cancer Network
- A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor Removal
- (2016) Lapatsanant Chaisiriwong et al. Oxidative Medicine and Cellular Longevity
- The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
- (2015) Tiziana Tataranni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Deferasirox chelation therapy in patients with transfusion-dependent MDS: a ‘real-world’ report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata
- (2015) Luca Maurillo et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Iron toxicity and its possible association with treatment of Cancer: Lessons from hemoglobinopathies and rare, transfusion-dependent anemias
- (2015) Mammen Puliyel et al. FREE RADICAL BIOLOGY AND MEDICINE
- ‘Ride on the ferrous wheel’ – The cycle of iron in macrophages in health and disease
- (2015) Manfred Nairz et al. IMMUNOBIOLOGY
- Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes
- (2015) Amer M Zeidan et al. Journal of Comparative Effectiveness Research
- Effects of Iron Overload on the Bone Marrow Microenvironment in Mice
- (2015) Yuchen Zhang et al. PLoS One
- ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
- (2015) Xiao Chai et al. Scientific Reports
- Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
- (2014) Ángel F. Remacha et al. ANNALS OF HEMATOLOGY
- The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia
- (2014) Ashish Banerjee et al. BRITISH JOURNAL OF HAEMATOLOGY
- The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome
- (2014) Arch G. Mainous et al. BRITISH JOURNAL OF HAEMATOLOGY
- Disease Progression in Myelodysplastic Syndromes: Do Mesenchymal Cells Pave the Way?
- (2014) Marc H.G.P. Raaijmakers Cell Stem Cell
- Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study
- (2014) Linéa Bonfils et al. DIABETOLOGIA
- Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
- (2014) Emanuele Angelucci et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice
- (2014) Hiroshi Okabe et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The Pathophysiology of Transfusional Iron Overload
- (2014) John B. Porter et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload
- (2014) Mariia Lunova et al. JOURNAL OF HEPATOLOGY
- Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
- (2014) Michel Delforge et al. LEUKEMIA RESEARCH
- Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload
- (2014) Kristýna Pimková et al. Oxidative Medicine and Cellular Longevity
- Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function
- (2014) Jasmine L. Hamilton et al. PLoS One
- Iron at the interface of immunity and infection
- (2014) Manfred Nairz et al. Frontiers in Pharmacology
- Design of Long Circulating Nontoxic Dendritic Polymers for the Removal of Iron in Vivo
- (2013) Muhammad Imran ul-haq et al. ACS Nano
- Hypoxia and Metabolic Properties of Hematopoietic Stem Cells
- (2013) Cheng Cheng Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors
- (2013) Rosangela Invernizzi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients, the GFM experience: response to Bowenet al
- (2013) Christian Rose et al. BRITISH JOURNAL OF HAEMATOLOGY
- Method Development and Validation for Ultra-High Pressure Liquid Chromatography/Tandem Mass Spectrometry Determination of Multiple Prostanoids in Biological Samples
- (2013) Rui Yu et al. JOURNAL OF AOAC INTERNATIONAL
- Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes
- (2013) Geane Felix de Souza et al. JOURNAL OF CLINICAL PATHOLOGY
- Oxidative Stress Levels in Myelodysplastic Syndrome Patients: Their Relationship to Serum Ferritin and Haemoglobin Values
- (2013) K Saigo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells
- (2013) Chunhong Gu et al. LEUKEMIA RESEARCH
- Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome
- (2013) Yang Jo Chung et al. LEUKEMIA RESEARCH
- The role of iron and reactive oxygen species in cell death
- (2013) Scott J Dixon et al. Nature Chemical Biology
- Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure
- (2013) Etienne Paubelle et al. PLoS One
- Iron: Protector or Risk Factor for Cardiovascular Disease? Still Controversial
- (2013) Carlos Muñoz-Bravo et al. Nutrients
- Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
- (2012) F. Nolte et al. ANNALS OF HEMATOLOGY
- Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population
- (2012) Massimo Breccia et al. ANNALS OF HEMATOLOGY
- Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells
- (2012) F. Kocabas et al. BLOOD
- Pharmacologic stabilization of HIF-1 increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation
- (2012) C. E. Forristal et al. BLOOD
- Meis1 preserves hematopoietic stem cells in mice by limiting oxidative stress
- (2012) Z. Unnisa et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
- (2012) Shohei Kikuchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
- (2012) N. Gattermann et al. HAEMATOLOGICA
- Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis
- (2012) Hiroyuki Itabe JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Adipocyte iron regulates adiponectin and insulin sensitivity
- (2012) J. Scott Gabrielsen et al. JOURNAL OF CLINICAL INVESTIGATION
- Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome
- (2012) Alan F. List et al. JOURNAL OF CLINICAL ONCOLOGY
- Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors
- (2012) Vinod Pullarkat et al. LEUKEMIA RESEARCH
- Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
- (2012) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes
- (2012) Julia Hartmann et al. LEUKEMIA RESEARCH
- Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease
- (2011) Michael Li-Hsuan Huang et al. ANTIOXIDANTS & REDOX SIGNALING
- A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
- (2011) P. Fenaux et al. BLOOD
- Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications
- (2011) Kallistheni Farmaki et al. BLOOD CELLS MOLECULES AND DISEASES
- Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome
- (2011) Hussam Ghoti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Elevated Transferrin Saturation and Risk of Diabetes: Three population-based studies
- (2011) C. Ellervik et al. DIABETES CARE
- The effect of iron overload and chelation on erythroid differentiation
- (2011) Kazuki Taoka et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Reactive oxygen species and hematopoietic stem cell senescence
- (2011) Lijian Shao et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
- (2011) Masayasu Jo et al. JOURNAL OF GASTROENTEROLOGY
- Congenital Sideroblastic Anemias: Iron and Heme Lost in Mitochondrial Translation
- (2011) M. D. Fleming Hematology-American Society of Hematology Education Program
- Iron overload in MDS—pathophysiology, diagnosis, and complications
- (2010) Norbert Gattermann et al. ANNALS OF HEMATOLOGY
- Iron metabolism and ineffective erythropoiesis in β-thalassemia mouse models
- (2010) Pedro Ramos et al. Annals of the New York Academy of Sciences
- Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging
- (2010) E. Messa et al. HAEMATOLOGICA
- Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
- (2010) H. Ghoti et al. HAEMATOLOGICA
- Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
- (2010) Stuart L. Goldberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
- (2010) Celine Callens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Erythropoiesis-stimulating agents in myelodysplastic syndromes
- (2010) Eva Hellström-Lindberg LEUKEMIA & LYMPHOMA
- Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
- (2010) Christian Rose et al. LEUKEMIA RESEARCH
- Daily labile plasma iron as an indicator of chelator activity inThalassaemia majorpatients
- (2009) Giuliana Zanninelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
- (2009) Junko H. Ohyashiki et al. CANCER SCIENCE
- The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms
- (2009) James W. Vardiman CHEMICO-BIOLOGICAL INTERACTIONS
- Iron Overload: Consequences, Assessment, and Monitoring
- (2009) Ali T. Taher et al. HEMOGLOBIN
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair
- (2008) Annahita Sallmyr et al. CANCER LETTERS
- Myocyte Damage and Loss of Myofibers is the Potential Mechanism of Iron Overload Toxicity in Congestive Cardiac Failure in Thalassemia. Complete Reversal of the Cardiomyopathy and Normalization of Iron Load by Deferiprone
- (2008) Annita Kolnagou et al. HEMOGLOBIN
- Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells
- (2008) Richard G. Ruddell et al. HEPATOLOGY
- Body iron metabolism and pathophysiology of iron overload
- (2008) Yutaka Kohgo et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Mitochondrial DNA Damage in Iron Overload
- (2008) Xueshan Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial
- (2008) L. R. Zacharski et al. JNCI-Journal of the National Cancer Institute
- Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
- (2008) Bozena Novotna et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now